牛牛AI助理已提取核心訊息
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of the company's stock on March 4, 2024. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the transaction, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Bourla after the action. This transaction is part of the regular financial disclosures made by company executives in compliance with SEC regulations.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of the company's stock on March 4, 2024. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the transaction, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Bourla after the action. This transaction is part of the regular financial disclosures made by company executives in compliance with SEC regulations.
輝瑞公司（PFE）董事長兼首席執行官阿爾伯特·布爾拉於2024年3月4日執行了該公司股票的交易。公告中未披露交易的具體細節，包括交易的股票數量、股票的性質、交易價格和交易的總價值。該報告也沒有提供有關Bourla在行動後持有的股票數量的信息。該交易是公司高管根據美國證券交易委員會法規定期披露財務信息的一部分。
輝瑞公司（PFE）董事長兼首席執行官阿爾伯特·布爾拉於2024年3月4日執行了該公司股票的交易。公告中未披露交易的具體細節，包括交易的股票數量、股票的性質、交易價格和交易的總價值。該報告也沒有提供有關Bourla在行動後持有的股票數量的信息。該交易是公司高管根據美國證券交易委員會法規定期披露財務信息的一部分。
有用
沒用